 <h1>Alendronate / cholecalciferol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of alendronate/cholecalciferol include:</b> hypocalcemia and hypophosphatemia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to alendronate/cholecalciferol: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, alendronate / cholecalciferol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking alendronate / cholecalciferol:</p><p>
<i>Less common</i>
</p><ul>
<li>Chest pain, discomfort, or burning</li>
<li>difficulty with swallowing</li>
<li>heartburn</li>
<li>muscle or bone pain</li>
<li>pain with swallowing</li>
<li>vomiting blood</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>chills</li>
<li>confusion</li>
<li>convulsions</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficulty with breathing</li>
<li>fever</li>
<li>irregular heartbeats</li>
<li>itching</li>
<li>joint pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>mood or mental changes</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>numbness and tingling around the mouth, fingertips, or feet</li>
<li>rapid weight gain</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>shortness of breath</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>swelling of the neck</li>
<li>tremor</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Burning upper abdominal or stomach pain</li>
<li>difficulty with moving</li>
<li>heavy jaw feeling</li>
<li>loosening of a tooth</li>
<li>loss of appetite</li>
<li>muscle aching or cramping</li>
<li>muscle pains or stiffness</li>
<li>pain or burning in the throat</li>
<li>pain, swelling, or numbness in the mouth or jaw</li>
<li>severe bone, joint, or muscle pain</li>
<li>stomach bloating, burning, cramping, or pain</li>
<li>swollen joints</li>
<li>weight loss</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of alendronate / cholecalciferol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>constipation</li>
<li>excess air or gas in the stomach or intestines</li>
<li>full feeling</li>
<li>headache</li>
<li>indigestion</li>
<li>passing gas</li>
<li>pressure in the stomach</li>
<li>stomach discomfort, upset, or pain</li>
<li>swelling of the abdominal or stomach area</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blurred vision or other change in vision</li>
<li>decreased vision</li>
<li>eye pain</li>
<li>eye redness</li>
<li>eye tenderness</li>
<li>flushing or redness of the skin</li>
<li>increased tearing</li>
<li>rash</li>
<li>redness of the eye</li>
<li>sensitivity of the eye to light</li>
<li>severe eye pain</li>
<li>tearing</li>
<li>unusually warm skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dizziness or lightheadedness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>general feeling of discomfort or illness</li>
<li>hair loss</li>
<li>hives or welts</li>
<li>lack or loss of strength</li>
<li>sensation of spinning</li>
<li>thinning of the hair</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alendronate / cholecalciferol: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse reactions are upper gastrointestinal adverse reactions including abdominal pain, dyspepsia, esophageal ulcer, dysphagia, abdominal distension and acid regurgitation.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decrease in serum calcium (18%), decrease in serum phosphate (10%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone, muscle, or join pain (sometimes severe)</p>
<p><b>Common</b> (1% to 10%): Joint swelling</p>
<p><b>Rare</b> (less than 0.1%): Osteonecrosis of the Jaw, atypical subtrochanteric and diaphyseal femoral fractures</p>
<p><b>Postmarketing reports</b>: Transient symptoms of myalgia (at the beginning of treatment); low-energy femoral shaft and subtrochanteric fractures<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Alopecia, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash erythema</p>
<p><b>Rare</b> (less than 0.1%): Rash with photosensitivity, severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis</p>
<p><b>Postmarketing reports</b>: Rash (occasionally with photosensitivity)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid regurgitation, esophageal ulcer, vomiting, dysphagia, abdominal distensions</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastritis, esophagitis, esophageal erosions, melena</p>
<p><b>Rare</b> (less than 0.1%): Esophageal stricture, oropharyngeal ulceration, upper gastrointestinal perforation, ulcers, bleeding</p>
<p><b>Postmarketing reports</b>: Gastric or duodenal ulcers (some severe and with complications)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Taste perversion (dysgeusia)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo, asthenia, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia, malaise</p>
<p><b>Rare</b> (less than 0.1%): Fever<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Eye inflammation, uveitis, scleritis, episcleritis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reactions including urticaria and angioedema</p>
<p><b>Frequency not reported</b>: Rash, erythema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Postmarketing reports</b>: Acute asthma exacerbations<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Fosamax Plus D (alendronate-cholecalciferol)." Merck &amp; Company Inc, West Point, PA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about alendronate / cholecalciferol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: bisphosphonates</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alendronate and cholecalciferol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Fosamax Plus D</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Osteoporosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alendronate / cholecalciferol: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse reactions are upper gastrointestinal adverse reactions including abdominal pain, dyspepsia, esophageal ulcer, dysphagia, abdominal distension and acid regurgitation.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decrease in serum calcium (18%), decrease in serum phosphate (10%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone, muscle, or join pain (sometimes severe)</p><p><b>Common</b> (1% to 10%): Joint swelling</p><p><b>Rare</b> (less than 0.1%): Osteonecrosis of the Jaw, atypical subtrochanteric and diaphyseal femoral fractures</p><p><b>Postmarketing reports</b>: Transient symptoms of myalgia (at the beginning of treatment); low-energy femoral shaft and subtrochanteric fractures<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Alopecia, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Rash erythema</p><p><b>Rare</b> (less than 0.1%): Rash with photosensitivity, severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis</p><p><b>Postmarketing reports</b>: Rash (occasionally with photosensitivity)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid regurgitation, esophageal ulcer, vomiting, dysphagia, abdominal distensions</p><p><b>Uncommon</b> (0.1% to 1%): Gastritis, esophagitis, esophageal erosions, melena</p><p><b>Rare</b> (less than 0.1%): Esophageal stricture, oropharyngeal ulceration, upper gastrointestinal perforation, ulcers, bleeding</p><p><b>Postmarketing reports</b>: Gastric or duodenal ulcers (some severe and with complications)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Taste perversion (dysgeusia)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo, asthenia, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia, malaise</p><p><b>Rare</b> (less than 0.1%): Fever<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Eye inflammation, uveitis, scleritis, episcleritis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reactions including urticaria and angioedema</p><p><b>Frequency not reported</b>: Rash, erythema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Postmarketing reports</b>: Acute asthma exacerbations<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Fosamax Plus D (alendronate-cholecalciferol)." Merck &amp; Company Inc, West Point, PA. </p><h2>More about alendronate / cholecalciferol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: bisphosphonates</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alendronate and cholecalciferol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Osteoporosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>